Bluebird Bio (BLUE) Takes Off on Promising Drug Results

Shares of Cambridge, Massachusetts based Bluebird Bio, Inc. (BLUE) rocketed on Tuesday, against the backdrop of a mixed market on Wall Street. Bluebird’s stock was up 72.39%, rising by $35.29 per share, to close at $84.28 on volume of 8,209,814 shares. It was Bluebird’s highest close ever. On Monday night, the company announced that one Read the full article... Read the rest of Bluebird Bio (BLUE) Takes Off on Promising Drug Results at InvestorGuide.com .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.